stockrowAxoGen, Inc. (AXGN) vs Haemonetics Corporation (HAE)
- AxoGen, Inc. AXGN 49.57 +1.68%
- Haemonetics Corporation HAE 119.98 −3.33%
AxoGen, Inc. and Haemonetics Corporation are both Medical Devices companies. Haemonetics Corporation is the larger, with a market value of $5.7B against $2.9B — 1.9× the size. AxoGen, Inc. has negative trailing earnings, so its P/E is not meaningful; Haemonetics Corporation trades at 54.5×. AxoGen, Inc. grew revenue faster over the last twelve months: 24.3% against 4.11%. Haemonetics Corporation has the higher net margin (7.52% vs −12.0%) and the higher return on invested capital (6.31% vs −5.27%). Across the 20 metrics below, Haemonetics Corporation leads on 14 and AxoGen, Inc. on 6.
Valuation
Profitability
| Metric | AXGN | HAE | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.18% | 59.63% | 57.76% |
| Operating margin | (5.17%) | 12.80% | (15.07%) |
| Net margin | (11.96%) | 7.52% | (14.45%) |
| Free cash flow margin | 7.50% | 24.95% | (3.88%) |
| Return on equity | (10.35%) | 11.89% | (10.35%) |
| Return on assets | (8.33%) | 4.28% | (17.26%) |
| Return on invested capital | (5.27%) | 6.31% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack